Together, these data indicate that the IRE1-XBP1 axis, rather than the PERK-CHOP axis, is activated in NSCLC, is associated with tumor growth, and may affect tumor aggressiveness. This evidence concerns the gene EIF2AK3 and non-small cell lung carcinoma.